ICON Acquires Mapi Group

Mapi Group Logo

Expands ICON's leadership in Health Outcomes Research and Commercialisation Services

A global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has acquired the Mapi Group, a leading Patient-Centered Health Outcomes Research and Commercialisation company, currently based in the Translation & Innovation Hub (I-HUB).

A full press release is available on the ICON website

Article text (excluding photos or graphics) © Imperial College London.

Photos and graphics subject to third party copyright used with permission or © Imperial College London.

Reporter

Press Office

Communications and Public Affairs